GX Pharma

About GX Pharma

Founded in 2008, GX Pharma is a contract research organization (CRO) that provides comprehensive solutions for clinical research services. The company is positioned as a key partner for entities in the pharmaceutical, biopharmaceutical, and medical device sectors, aiming to accelerate the marketization process for their clients' products. Based in Beijing, China, GX Pharma operates as a private entity with significant backing from investors, having raised $44.3 million to date.

GX Pharma's business model is centered on delivering integrated services that span the entire product development lifecycle. The firm specializes in providing clinical research services and facilitating registration applications for drugs, biologics, and medical devices. This approach is designed to shorten the time-to-market for their clients' products. The company's clientele includes some of the largest pharmaceutical and biopharmaceutical companies, whom they support through consulting and advisory services on an international scale. Revenue is generated by offering these specialized, project-based services which are scalable to meet the specific needs of each client, from providing a single consultant to a full managed services team.

The service portfolio of GX Pharma is extensive, covering critical areas such as regulatory compliance, quality assurance, and various forms of validation including equipment, process, cleaning, and computer systems. The firm has a strong focus on GxP standards, which encompass good practices in manufacturing (GMP), distribution (GDP), engineering (GEP), and laboratory (GLP) settings. They offer a suite of services that includes commissioning, qualification, and validation (CQV), third-party audits, data management and statistical analysis, and specialized support for vaccine clinical research. By outsourcing these complex needs to GX Pharma, client companies can concentrate on their core business functions.